<?xml version="1.0" encoding="UTF-8"?>
<VIOLIN>
	<pathogen pathogen_id="pathogen41">
		<pathogen_name>Clostridium tetani</pathogen_name>
		<taxon_id>1485</taxon_id>
		<pathogenesis refs="reference711">C. tetani typically enters a host through a wound. C. tetani produces two exotoxins, tetanolysin and tetanospasmin. Eleven strains of C. tetani have been identified, which differ primarily in flagellar antigens and in its ability to produce tetanospasmin. All toxigenic strains contain a plasmid that produces identical toxins. Tetanospasmin is a neurotoxin, one of the most potent toxins known. Tetanospasmin causes the clinical manifestations of tetanus. Tetanospasmin is distributed in the blood and lymphatic system. The toxin enters the nerve axon, transports across synaptic junctions, and finally reaches the central nervous system. It  is then rapidly fixed to gangliosides at the presynaptic junctions of inhibitory motor nerve endings. The tetanus toxin blocks inhibitory impulses by interfering with the release of neurotransmitters, including glycine and gamma-aminobutyric acid. The clinical manifestations of tetanus include unopposed muscle contraction and spasm (Brook, 2008).</pathogenesis>
		<disease_name>Tetanus</disease_name>
		<protective_immunity refs=""></protective_immunity>
		<host_range refs=""></host_range>
		<introduction refs="reference711">Clostridium tetani is a Gram-positive, rod-shaped, anaerobic bacterium of the genus Clostridium. C. tetani is found as spores in soil or as parasites in the gastrointestinal tract of animals. C. tetani produces the toxin tetanospasmin and is the causative agent of tetanus. Tetanus can be prevented by immunization with tetanal toxoid and appropriate wound care. Specific therapy includes intramuscular administration of tetanus immunoglobulin to neutralize circulating toxin before it binds to neuronal cell membranes (Brook, 2008).</introduction>
	</pathogen>

	<host host_id="host55">
		<common_name>Baboon</common_name>
		<scientific_name>Papio cynocephalus</scientific_name>
		<taxon_id>9556</taxon_id>
    </host>
	<host host_id="host43">
		<common_name>Bank vole</common_name>
		<scientific_name>Clethrionomys glareolus</scientific_name>
		<taxon_id>447135</taxon_id>
    </host>
	<host host_id="host31">
		<common_name>Bear</common_name>
		<scientific_name>Ursus americanus</scientific_name>
		<taxon_id>9643</taxon_id>
    </host>
	<host host_id="host51">
		<common_name>Birds</common_name>
		<scientific_name>Passeroidea</scientific_name>
		<taxon_id>175121</taxon_id>
    </host>
	<host host_id="host35">
		<common_name>Brown Trout</common_name>
		<scientific_name>Salmo trutta</scientific_name>
		<taxon_id>8032</taxon_id>
    </host>
	<host host_id="host30">
		<common_name>Buffalo</common_name>
		<scientific_name>Bison bison</scientific_name>
		<taxon_id>9901</taxon_id>
    </host>
	<host host_id="host53">
		<common_name>Carnivores</common_name>
		<scientific_name>Vulpes</scientific_name>
		<taxon_id>9625</taxon_id>
    </host>
	<host host_id="host37">
		<common_name>Cat</common_name>
		<scientific_name>Felis catus</scientific_name>
		<taxon_id>9685</taxon_id>
    </host>
	<host host_id="host52">
		<common_name>Catfishes</common_name>
		<scientific_name>Siluriformes</scientific_name>
		<taxon_id>7995</taxon_id>
    </host>
	<host host_id="host12">
		<common_name>Cattle</common_name>
		<scientific_name>Bos taurus</scientific_name>
		<taxon_id>9913</taxon_id>
    </host>
	<host host_id="host8">
		<common_name>Chicken</common_name>
		<scientific_name>Gallus gallus</scientific_name>
		<taxon_id>9031</taxon_id>
    </host>
	<host host_id="host42">
		<common_name>Chimpanzee</common_name>
		<scientific_name>Pan troglodytes</scientific_name>
		<taxon_id>9598</taxon_id>
    </host>
	<host host_id="host26">
		<common_name>chinchillas</common_name>
		<scientific_name>Chinchillidae</scientific_name>
		<taxon_id>10150</taxon_id>
    </host>
	<host host_id="host24">
		<common_name>Copper Pheasant</common_name>
		<scientific_name>Syrmaticus soemmerringii</scientific_name>
		<taxon_id>9067</taxon_id>
    </host>
	<host host_id="host29">
		<common_name>Deer</common_name>
		<scientific_name>Cervus elaphus</scientific_name>
		<taxon_id>9860</taxon_id>
    </host>
	<host host_id="host32">
		<common_name>Deer mouse</common_name>
		<scientific_name>Peromyscus maniculatus</scientific_name>
		<taxon_id>10042</taxon_id>
    </host>
	<host host_id="host36">
		<common_name>Dog</common_name>
		<scientific_name>Canis familiaris</scientific_name>
		<taxon_id>9615</taxon_id>
    </host>
	<host host_id="host9">
		<common_name>Ducks</common_name>
		<scientific_name>Anas</scientific_name>
		<taxon_id>8835</taxon_id>
    </host>
	<host host_id="host19">
		<common_name>Ferret</common_name>
		<scientific_name>Mustela putorius furo</scientific_name>
		<taxon_id>9669</taxon_id>
    </host>
	<host host_id="host48">
		<common_name>Fish</common_name>
		<scientific_name>Hyperotreti</scientific_name>
		<taxon_id>117565</taxon_id>
    </host>
	<host host_id="host41">
		<common_name>Gerbil</common_name>
		<scientific_name>Gerbillina</scientific_name>
		<taxon_id>10045</taxon_id>
    </host>
	<host host_id="host13">
		<common_name>Goat</common_name>
		<scientific_name>Capra hircus</scientific_name>
		<taxon_id>9925</taxon_id>
    </host>
	<host host_id="host47">
		<common_name>Gray wolf</common_name>
		<scientific_name>Canis lupus</scientific_name>
		<taxon_id>9612</taxon_id>
    </host>
	<host host_id="host7">
		<common_name>Guinea pig</common_name>
		<scientific_name>Cavia porcellus</scientific_name>
		<taxon_id>10141</taxon_id>
    </host>
	<host host_id="host16">
		<common_name>Hamster</common_name>
		<scientific_name>Mesocricetus auratus</scientific_name>
		<taxon_id>10036</taxon_id>
    </host>
	<host host_id="host18">
		<common_name>Horse</common_name>
		<scientific_name>Equus caballus</scientific_name>
		<taxon_id>9796</taxon_id>
    </host>
	<host host_id="host2">
		<common_name>Human</common_name>
		<scientific_name>Homo sapiens</scientific_name>
		<taxon_id>9606</taxon_id>
    </host>
	<host host_id="host39">
		<common_name>Macaque</common_name>
		<scientific_name>Macaca fascicularis</scientific_name>
		<taxon_id>9541</taxon_id>
    </host>
	<host host_id="host40">
		<common_name>Mongolian Gerbil</common_name>
		<scientific_name>Meriones unguiculatus</scientific_name>
		<taxon_id>10047</taxon_id>
    </host>
	<host host_id="host5">
		<common_name>Monkey</common_name>
		<scientific_name>Platyrrhini</scientific_name>
		<taxon_id>9479</taxon_id>
    </host>
	<host host_id="host3">
		<common_name>Mouse</common_name>
		<scientific_name>Mus musculus</scientific_name>
		<taxon_id>10090</taxon_id>
    </host>
	<host host_id="host59">
		<common_name>None</common_name>
		<scientific_name>None</scientific_name>
		<taxon_id></taxon_id>
    </host>
	<host host_id="host50">
		<common_name>Parrot</common_name>
		<scientific_name>Psittacidae</scientific_name>
		<taxon_id>9224</taxon_id>
    </host>
	<host host_id="host15">
		<common_name>Pig</common_name>
		<scientific_name>Sus scrofa</scientific_name>
		<taxon_id>9823</taxon_id>
    </host>
	<host host_id="host6">
		<common_name>Rabbit</common_name>
		<scientific_name>Oryctolagus cuniculus</scientific_name>
		<taxon_id>9986</taxon_id>
    </host>
	<host host_id="host45">
		<common_name>Rainbow trout</common_name>
		<scientific_name>Oncorhynchus mykiss</scientific_name>
		<taxon_id>8022</taxon_id>
    </host>
	<host host_id="host4">
		<common_name>Rat</common_name>
		<scientific_name>Rattus</scientific_name>
		<taxon_id>10114</taxon_id>
    </host>
	<host host_id="host34">
		<common_name>Raven</common_name>
		<scientific_name>Corvus corax</scientific_name>
		<taxon_id>56781</taxon_id>
    </host>
	<host host_id="host54">
		<common_name>sei whale</common_name>
		<scientific_name>Balaenoptera borealis</scientific_name>
		<taxon_id>9768</taxon_id>
    </host>
	<host host_id="host17">
		<common_name>Sheep</common_name>
		<scientific_name>Ovis aries</scientific_name>
		<taxon_id>9940</taxon_id>
    </host>
	<host host_id="host28">
		<common_name>Squirrel</common_name>
		<scientific_name>Spermophilus richardsonii</scientific_name>
		<taxon_id>37591</taxon_id>
    </host>
	<host host_id="host44">
		<common_name>Tree shrew</common_name>
		<scientific_name>Tupaiidae</scientific_name>
		<taxon_id>9393</taxon_id>
    </host>
	<host host_id="host49">
		<common_name>Trouts, salmons &amp; chars</common_name>
		<scientific_name>Salmoninae</scientific_name>
		<taxon_id>504568</taxon_id>
    </host>
	<host host_id="host38">
		<common_name>Turkey</common_name>
		<scientific_name>Meleagris gallopavo</scientific_name>
		<taxon_id>9103</taxon_id>
    </host>
	<host host_id="host33">
		<common_name>Vole</common_name>
		<scientific_name>Microtus ochrogaster</scientific_name>
		<taxon_id>79684</taxon_id>
    </host>
	<host host_id="host27">
		<common_name>Water buffalo</common_name>
		<scientific_name>Bubalus bubalis</scientific_name>
		<taxon_id>391902</taxon_id>
    </host>
	<vaccine vaccine_id="vaccine555">
		<vaccine_name>Actacel</vaccine_name>
		<proper_name></proper_name>
		<brand_name>Actacel</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0010705</vo_id>
		<type>Subunit vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + Conjugate.</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine383">
		<vaccine_name>Adacel</vaccine_name>
		<proper_name>Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed</proper_name>
		<brand_name>Adacel</brand_name>
		<manufacturer>Sanofi Pasteur, Ltd (USA: License #1726)</manufacturer>
		<vo_id>VO_0000005</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA: License #1726</location_licensed>
		<description refs="reference806">It is a sterile liquid suspension of tetanus and diphtheria toxoids and acellular pertussis components adsorbed onto aluminum phosphate, for intramuscular administration.(FDA: Adacel)</description>
		<adjuvant refs="">aluminum phosphate</adjuvant>
		<storage refs="">Adacel vaccine should be stored at 2° to 8°C (35° to 46°F). DO NOT FREEZE</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference806">Clostridium tetani is grown in modified Mueller-Miller casamino acid medium without beef heart infusion. Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration. Diphtheria and tetanus toxoids are individually adsorbed onto aluminum phosphate.(FDA: Adacel)</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs="">Pertussis</antigen>
		<host_response host_response_id="host_response481" host_id="host2">
			<immune_response refs="reference806">Strong antibody response was induced after the first immunization. The antibody response after booster immunization was also strong, esp. for young age group. The Adacel-induced immune response levels after the first immunization and booster immunization were comparable to those induced by a US licensed Tetanus and Diphtheria Toxoids Adsorbed For Adult Use (Td) vaccine manufactured by Sanofi Pasteur Inc., Swiftwater, PA (FDA: Adacel).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs="reference806">The use of Adacel vaccine as a primary series, or to complete the primary series, has not been studied. Vaccination with Adacel vaccine may not protect all of vaccinated individuals (FDA: Adacel).</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference806">A severe allergic reaction (e.g., anaphylaxis) after a previous dose of Adacel vaccine. Also, headache, body ache or muscle weakness, tiredness, chills, sore and swollen joints, nausea, lymph node swelling, diarrhea, vomiting, and rash may result.(FDA: Adacel)</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine5583">
		<vaccine_name>Adacel-Polio</vaccine_name>
		<proper_name>Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine</proper_name>
		<brand_name>Adacel-Polio</brand_name>
		<manufacturer>Sanofi Pasteur SA</manufacturer>
		<vo_id></vo_id>
		<type>Toxoid vaccine + Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="reference4106">ADACEL®-POLIO is a sterile, uniform, cloudy, white suspension of tetanus and diphtheria toxoids and acellular pertussis vaccine adsorbed separately on aluminum phosphate and combined with inactivated poliomyelitis vaccine (vero cell origin) types 1, 2 and 3, and suspended in water for injection. Acellular pertussis vaccine is composed of five purified pertussis antigens (PT, FHA, PRN and FIM). (Product Monograph: Adacel-Polio)</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F), do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine385">
		<vaccine_name>Boostrix</vaccine_name>
		<proper_name>Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed</proper_name>
		<brand_name>Boostrix</brand_name>
		<manufacturer>GlaxoSmithKline Biologicals</manufacturer>
		<vo_id>VO_0000015</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1617)</location_licensed>
		<description refs="reference809">BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) is a noninfectious, sterile, vaccine for intramuscular administration. It contains tetanus toxoid, diphtheria toxoid, and pertussis antigens (inactivated pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA] and pertactin). The antigens are the same as those in INFANRIX, but BOOSTRIX is formulated with reduced quantities of these antigens (FDA Boostrix).</description>
		<adjuvant refs="">aluminum Phosphate</adjuvant>
		<storage refs="">Store refrigerated between 2º and 8ºC (36º and 46ºF). Do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference809">Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein.  Toxins are detoxified with formaldehyde, concentrated by ultrafiltration, and purified by precipitation, dialysis, and sterile filtration (FDA Boostrix).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response483" host_id="host2">
			<immune_response refs="reference809">In Boostrix, N=1440 to 1444, pre-vaccination levels in a 95% confidence interval were 85.2, while post-vaccination levels at a 95% confidence interval were 98.2 (FDA Boostrix).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs="">BOOSTRIX is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis as a single dose.</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference809">: Common solicited adverse events (≥15%) in adolescents were pain, redness, and swelling at the injection site, increase in arm circumference of injected arm, headache, fatigue, and gastrointestinal symptoms (FDA Boostrix).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine5584">
		<vaccine_name>Boostrix-Polio</vaccine_name>
		<proper_name>Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine</proper_name>
		<brand_name>Boostrix-Polio</brand_name>
		<manufacturer>GlaxoSmithKline</manufacturer>
		<vo_id></vo_id>
		<type>Toxoid vaccine + Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="reference4107">BOOSTRIX®-POLIO (combined diphtheria, tetanus, acellular pertussis and inactivated poliomyetitis) vaccine contains diphtheria toxoid, tetanus toxoid, three purified pertussis antigens [pertussis toxoid (PT), filamentous haemagglutinin (FHA) and pertactin (69 kDalton outer membrane protein)] adsorbed onto aluminum salts and inactivated polio virus types 1, 2 and 3. (GSK: Boostrix-Polio)</description>
		<adjuvant refs="">Aluminum hydroxide</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F), do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine3672">
		<vaccine_name>C. tetani DNA vaccine pcDNA3tetC encoding fragment C</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer></manufacturer>
		<vo_id>VO_0004414</vo_id>
		<type>DNA vaccine</type>
		<status>Research</status>
		<vector>pcDNA3 [Ref2333:Anderson et al., 1997]</vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed></location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>

		<gene_engineering gene_engineering_id="gene_engineering1206" gene_id="gene451">
			<type>Recombinant protein preparation</type>
			<description refs="reference2333">Vector pcDNA3 expressed fragment C (Anderson et al., 1997).</description>
		</gene_engineering>
		<host_response host_response_id="host_response1443" host_id="host3">
			<immune_response refs="reference2333">Anti-Fragment C serum immunoglobulin and proliferative responses in splenocytes were observed following two immunizations with pcDNA3/tetC (Anderson et al., 1997).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs="">VO_0000286</immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference2333">Immunization of mice with Fragment C protein, the non-toxic C-terminal domain of tetanus toxin, protects mice against lethal challenge with tetanus toxin.  Seven out of ten immunized mice were protected (Anderson et al., 1997).</protection_efficacy>
			<side_effects refs=""></side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine363">
		<vaccine_name>DAPTACEL</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed</proper_name>
		<brand_name>DAPTACEL</brand_name>
		<manufacturer>Sanofi Pasteur, Ltd.</manufacturer>
		<vo_id>VO_0000029</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA (License #1726)</location_licensed>
		<description refs="">DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age.</description>
		<adjuvant refs=""></adjuvant>
		<storage refs="">should be stored at 2° to 8°C (35° to 46°F). DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference787">Clostridium tetani is grown in modified Mueller-Miller casamino acid medium without beef heart infusion.  Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration (FDA: DAPTACEL).</preparation>
		<route refs=""></route>
		<antigen refs="reference787">Isotonic suspension of pertussis antigens and diphtheria and tetanus toxoids (FDA: DAPTACEL).</antigen>
		<host_response host_response_id="host_response458" host_id="host2">
			<immune_response refs="reference787">One clinical study found that among a random subset of children who received the fourth dose of DAPTACEL vaccine at 15-16 months of age, 96.5% achieved diphtheria antitoxin levels of ≥1.0 IU/mL after the fourth dose. (FDA: DAPTACEL).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference787">A tetanus antitoxin level ≥0.1 IU/mL as measured by the ELISA used in clinical studies of DAPTACEL vaccine is considered protective (FDA: DAPTACEL).</protection_efficacy>
			<side_effects refs="reference787">The most common side effects reported are: injection site reactions, fussiness/irritability, inconsolable crying, and decreased activity/lethargy, and fever (FDA: DAPTACEL).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine386">
		<vaccine_name>Decavac</vaccine_name>
		<proper_name>Tetanus and Diphtheria Toxoids Adsorbed For Adult Use</proper_name>
		<brand_name>Decavac</brand_name>
		<manufacturer>Sanofi Pasteur, Inc</manufacturer>
		<vo_id>VO_0000030</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1725)</location_licensed>
		<description refs="reference810">It is for intramuscular injection, and is a sterile suspension of alum (aluminum potassium sulfate)-precipitated toxoids in an isotonic sodium chloride solution (FDA Decavac).</description>
		<adjuvant refs="">aluminum potassium sulfate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F). Do not freeze. Do not use vaccine after expiration date.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference810">Clostridium tetani cultures are grown in a peptone-based medium containing an extract of bovine muscle tissue.  The toxins are produced during the growth of the cultures are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration, and adsorbed onto alum (FDA Decavac).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response484" host_id="host2">
			<immune_response refs=""></immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference810">The results that indicated protective levels of antibody were achieved in greater than 90% of the study population after primary immunization with both components. Booster effects were achieved in 100% of the individuals with pre-existing antibody responses (FDA Decavac).</protection_efficacy>
			<side_effects refs="reference810">Side effects include: erythema, tenderness and induration at the injection site and 2% systemic reactions consisting of headache, malaise and temperature elevations. Boosters can accentuate side effects (FDA Decavac).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine362">
		<vaccine_name>Diphtheria &amp; Tetanus Toxoids Adsorbed</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids Adsorbed</proper_name>
		<brand_name>No Tradename</brand_name>
		<manufacturer>Sanofi Pasteur Inc</manufacturer>
		<vo_id>VO_0000033</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (FDA License #1725), Canada</location_licensed>
		<description refs="reference786">This vaccine is for intramuscular use. It is a sterile suspension of alum-precipitated (aluminum potassium sulfate) toxoid in an isotonic sodium chloride solution (FDA: dttadLB).</description>
		<adjuvant refs="">aluminum potassium sulfate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F). DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs="">Clostridium tetani cultures are grown in a peptone-based medium containing bovine extract.  Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs="reference786">Detoxified toxins from Corynebacterium diphtheriae and Clostridium tetani (FDA: dttadLB)</antigen>
		<host_response host_response_id="host_response457" host_id="host2">
			<immune_response refs="reference786">In one clinical trial, protective levels of diphtheria and tetanus antitoxins were detected in 100% of the children following two doses of the vaccine (FDA: dttadLB).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference786">A complete vaccination series substantially reduces the risk of developing diphtheria, and vaccinated persons who develop disease have milder illness. Protection lasts at least 10 years. Vaccination does not, however, eliminate carriage of C. diphtheriae in the pharynx or nose or on the skin (FDA: dttadLB).</protection_efficacy>
			<side_effects refs="reference786">Adverse reactions may be local and include redness, warmth, edema, induration, with or without tenderness, as well as urticaria, and rash. Malaise, transient fever, pain, hypotension, nausea and arthralgia may develop as well (FDA: dttadLB).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine2752">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc., Intervet Inc.</manufacturer>
		<vo_id>VO_0002266</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2759">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.27)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002268</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2763">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4867.20)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002269</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2767">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4867.21)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002270</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2742">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.00)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Colorado Serum Company, Merial, Inc.</manufacturer>
		<vo_id>VO_0002263</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2745">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.01)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002264</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2748">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.21)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002265</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2755">
		<vaccine_name>Encephalomyelitis Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.26)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002267</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2786">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002271</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2790">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.24)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002272</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2794">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.A0)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002273</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2798">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.A1)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002274</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2770">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.20)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002248</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2773">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002249</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2776">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.24)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002250</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2779">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.45)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002251</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2782">
		<vaccine_name>Encephalomyelitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.46)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002252</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2801">
		<vaccine_name>Encephalomyelitis-Influenza-West Nile Virus Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 46W5.21)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002238</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2805">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4844.30)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002253</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2831">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.22)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002258</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2837">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002259</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2843">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.24)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002260</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2849">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.32)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002261</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2810">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002254</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2815">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.24)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002255</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2820">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.32)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002256</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2825">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.33)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002257</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2855">
		<vaccine_name>Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Eastern &amp; Western, Killed Virus, Killed Flavivirus Chimera Vaccine-Tetanus Toxoid (USDA: 4855.R2)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Intervet Inc.</manufacturer>
		<vo_id>VO_0002262</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2860">
		<vaccine_name>Encephalomyelitis-West Nile Virus Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.20)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002284</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2873">
		<vaccine_name>Encephalomyelitis-West Nile Virus Eastern &amp; Western &amp; Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.23)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002287</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2864">
		<vaccine_name>Encephalomyelitis-West Nile Virus Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.21)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Boehringer Ingelheim Vetmedica, Inc.</manufacturer>
		<vo_id>VO_0002285</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2868">
		<vaccine_name>Encephalomyelitis-West Nile Virus Eastern &amp; Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.22)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Wyeth</manufacturer>
		<vo_id>VO_0002286</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine2877">
		<vaccine_name>Encephalomyelitis-West Nile Virus Eastern &amp; Western, Killed Virus, Live Canarypox Vector Vaccine-Tetanus Toxoid (USDA: 48W9.R0)</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer>Merial, Inc.</manufacturer>
		<vo_id>VO_0002288</vo_id>
		<type>Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA</location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine361">
		<vaccine_name>Infanrix</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed</proper_name>
		<brand_name>Infanrix</brand_name>
		<manufacturer>GlaxoSmithKline Biologicals</manufacturer>
		<vo_id>VO_0000064</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA (License #1617 ), Canada</location_licensed>
		<description refs="reference785">The vaccine is an noninfectious, sterile combination of diphtheria and tetanus toxoids and 3 pertussis antigens [inactivated pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (69 kiloDalton outer membrane protein)] adsorbed onto aluminum hydroxide (FDA Infanrix).</description>
		<adjuvant refs="">Aluminum Hydroxide</adjuvant>
		<storage refs="">Store INFANRIX refrigerated between 2° and 8°C (36° and 46°F). Do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference785">Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein.  The toxin is detoxified with formaldehyde, concentrated by ultrafiltration, and purified by precipitation, dialysis, and sterile filtration (FDA Infanrix).</preparation>
		<route refs=""></route>
		<antigen refs="reference785">Diphtheria and tetanus toxoids and 3 pertussis antigens [inactivated pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (69 kiloDalton outer membrane protein)] (FDA Infanrix).</antigen>
		<host_response host_response_id="host_response456" host_id="host2">
			<immune_response refs="reference785">Ninety percent of infants who received Hib simultaneously with INFANRIX achieved anti-PRP antibodies &gt;1 mcg/mL (N = 72), and 96% to 100% of infants who received OPV simultaneously with INFANRIX showed protective neutralizing antibody to poliovirus Types 1, 2, and 3 (N = 60-61) (FDA Infanrix).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference785">Injection site reactions, irritability, drowsiness, loss of appetite, vomiting, and crying (FDA Infanrix).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine593">
		<vaccine_name>Infanrix -IPV/Hib</vaccine_name>
		<proper_name>Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)</proper_name>
		<brand_name>Infanrix -IPV/Hib</brand_name>
		<manufacturer>GlaxoSmithKline</manufacturer>
		<vo_id>VO_0010722</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.</description>
		<adjuvant refs="">Aluminum Hydroxide</adjuvant>
		<storage refs="">Store in a refrigerator (2°C – 8°C).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine579">
		<vaccine_name>Infanrix-hexa</vaccine_name>
		<proper_name>Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine</proper_name>
		<brand_name>Infanrix-hexa</brand_name>
		<manufacturer>GlaxoSmithKline</manufacturer>
		<vo_id>VO_0010719</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.</description>
		<adjuvant refs="">Aluminum phosphate and aluminum hydroxide</adjuvant>
		<storage refs="">Should be stored at 2° to 8°C (35° to 46°F).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine589">
		<vaccine_name>Infanrix-IPV</vaccine_name>
		<proper_name>Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)</proper_name>
		<brand_name>Infanrix-IPV</brand_name>
		<manufacturer>GlaxoSmithKline</manufacturer>
		<vo_id>VO_0010721</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + killed virus. Other components: Formaldehyde, Polysorbate 80.</description>
		<adjuvant refs="">Aluminum hydroxide</adjuvant>
		<storage refs="">Store in a refrigerator (2°C - 8°C).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine585">
		<vaccine_name>Infanrix/Hib</vaccine_name>
		<proper_name>Diphtheria-tetanus-acellular pertussis and Haemophilus influenzae type b (Hib) vaccine.</proper_name>
		<brand_name>Infanrix/Hib</brand_name>
		<manufacturer>GlaxoSmithKline</manufacturer>
		<vo_id>VO_0010720</vo_id>
		<type>Subunit vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + conjugate. Other components: Formaldehyde, Lactose.</description>
		<adjuvant refs="">Aluminum hydroxide</adjuvant>
		<storage refs="">Store at 2°C – 8°C (in a refrigerator).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine365">
		<vaccine_name>KINRIX</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine</proper_name>
		<brand_name>KINRIX</brand_name>
		<manufacturer>GlaxoSmithKline Biologicals</manufacturer>
		<vo_id>VO_0000067</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1617)</location_licensed>
		<description refs=""></description>
		<adjuvant refs="">Aluminum Hydroxide</adjuvant>
		<storage refs="">Store refrigerated between 2° and 8°C (36° and 46°F). Do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference789">Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein.  The toxin is then detoxified with formaldehyde, concentrated by ultrafiltration, and purified by recipitation, dialysis, and sterile filtration (FDA: KINRIX).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs="reference789">Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussin toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), 8 mcg of pertactin (69 kiloDalton outer membrane protein), 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney), 8 DU of Type 2 poliovirus (MEF-1), and 32 DU of Type 3 poliovirus (Saukett) (FDA: KINRIX). 
The diphtheria, tetanus, and pertussis components of KINRIX are the same as those in INFANRIX and PEDIARIX and the poliovirus component is the same as that in PEDIARIX (FDA: KINRIX).</antigen>
		<host_response host_response_id="host_response460" host_id="host2">
			<immune_response refs="reference789">After vaccination, antibody levels in clinical trials was determined to be between 85-100% for all subjects (FDA: KINRIX).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference789">The most common side effects reported are: local injection site reactions, drowsiness, fever and loss of appetite (FDA: KINRIX).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine605">
		<vaccine_name>Pediacel</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)</proper_name>
		<brand_name>Pediacel</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0010730</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine364">
		<vaccine_name>Pediarix</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined</proper_name>
		<brand_name>Pediarix</brand_name>
		<manufacturer>GlaxoSmithKline Biologicals</manufacturer>
		<vo_id>VO_0000082</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1617)</location_licensed>
		<description refs="reference788">The vaccine contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA] and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett) (FDA: Pediarix).</description>
		<adjuvant refs="">Aluminum Hydroxide</adjuvant>
		<storage refs="">Store PEDIARIX refrigerated between 2º and 8ºC (36º and 46ºF). Do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference788">Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein.  The toxin is then detoxified with formaldehyde, concentrated by ultrafiltration, and purified by precipitation, dialysis, and sterile filtration (FDA: Pediarix).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response459" host_id="host2">
			<immune_response refs="">In response to vaccination, all patients seem to have around 90-100% antibody response.</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="">Following immunization, protection persists for at least 10 years.</protection_efficacy>
			<side_effects refs="">Most common side effects reported are: local injection site reactions, fever, fussiness/irritability, and loss of appetite.</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine367">
		<vaccine_name>Pentacel</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine</proper_name>
		<brand_name>Pentacel</brand_name>
		<manufacturer>Sanofi Pasteur Limited</manufacturer>
		<vo_id>VO_0000084</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1726), Canada</location_licensed>
		<description refs="reference790">It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday) (FDA: Pentacel).</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F). Do not freeze</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference790">Clostridium tetani is grown in modified Mueller-Miller casamino acid medium. Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration. Diphtheria and tetanus toxoids are individually adsorbed onto aluminum phosphate (FDA: Pentacel).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response466" host_id="host2">
			<immune_response refs="reference790">There was no evidence for interference in the immune response to the fourth dose of PCV7 (percent of participants with antibody levels ≥0.15 μg/mL and ≥0.5 μg/mL and GMCs to each serotype) administered at 15 months of age concomitantly with Pentacel vaccine (N = 155) (FDA: Pentacel).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference790">Injection site reactions include: Redness, swelling, tenderness, and an increase in arm circumference. The Systemic reactions include: fever, decreased activity, inconsolable crying, and irritability (FDA: Pentacel).</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine624">
		<vaccine_name>Quadracel</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed   Combined with Inactivated Poliomyelitis Vaccine</proper_name>
		<brand_name>Quadracel</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0010736</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Glutaraldehyde, Polysorbate 80.</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2 to 8C (35 to 46F). Do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine4203">
		<vaccine_name>rCMV-TT</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer></manufacturer>
		<vo_id>VO_0004718</vo_id>
		<type>Recombinant vector vaccine</type>
		<status>Research</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed></location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs="reference3242">Cytomegalovirus (CMV)-based vaccine platform (Tierney et al., 2012).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response1882" host_id="host3">
			<immune_response refs=""></immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs="reference3242">Mice were inoculated with a single intraperitoneal (i.p.) dose (5 × 10^6 pfu) of either MCMV/TetC or wild type (WT) MCMV (Δm157) control (Tierney et al., 2012).</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs="">VO_0003057</immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference3242">Results show that the protective levels of anti-tetanus antibodies that are durable (lasting &gt;13 months) in mice following only a single dose. This study demonstrates the ability of a 'single-dose' CMV-based vaccine strategy to induce durable protection, and supports the potential for a tetanus vaccine based on CMV to impact the incidence of tetanus in developing countries (Tierney et al., 2012).</protection_efficacy>
			<side_effects refs=""></side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine4151">
		<vaccine_name>Streptococcus gordonii-TTFC</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer></manufacturer>
		<vo_id>VO_0004669</vo_id>
		<type>Recombinant vector vaccine</type>
		<status>Research</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed></location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs="reference3340">Recombinant S. gordonii expressing TTFC (Medaglini et al., 2001)</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response1883" host_id="host3">
			<immune_response refs=""></immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs="">For each mouse strain two groups were inoculated respectively with vaccine strain GP1253 (n=26) and control strain GP1252 (n=14). Mice were inoculated twice, at 3 weeks intervals, with 10^9 CFU of bacteria in a volume of 100 μl/mouse. Two groups of 16 BALB/c mice each were inoculated intranasally with vaccine strain GP1253 or control strain GP1252.</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs="">VO_0000287</immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="">A total of 82% of vaccinated BALB/c mice were protected from the lethal challenge with 50 LD(50) of tetanus toxin (TT) and a direct correlation between the serum TTFC-specific IgG concentration and survival time of unprotected animals was observed. Intranasal immunization of BALB/c mice was also effective in inducing TTFC-specific serum IgG and local IgA in lung washes. Furthermore, 38% of animals immunized intranasally were protected from the lethal challenge with 10 LD(50) of TT while all control animals died within 24 h.</protection_efficacy>
			<side_effects refs=""></side_effects>
			<challenge_protocol refs="">Mice immunized with vaccine strain GP1253 or control strain GP1252 were challenged with 50 or 10 LD50 of TT corresponding to 100 and 20 ng/mouse. TT was diluted in sterile PBS and administered subcutaneously in a volume of 100 μl/mouse.</challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine627">
		<vaccine_name>Td Adsorbed</vaccine_name>
		<proper_name>Tetanus and Diphtheria Toxoids Adsorbed</proper_name>
		<brand_name>Td Adsorbed</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0010739</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Td ADSORBED is a sterile, cloudy, uniform suspension of tetanus and diphtheria toxoids adsorbed on aluminum phosphate asuspended in isotonic sodium chloride solution for intramuscular injection only.</description>
		<adjuvant refs="">aluminum phosphate</adjuvant>
		<storage refs="">Store at 2º to 8ºC (35º to 46ºF).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine628">
		<vaccine_name>Td Polio Adsorbed</vaccine_name>
		<proper_name>Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine</proper_name>
		<brand_name>Td Polio Adsorbed</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0011482</vo_id>
		<type>Subunit vaccine + Inactivated or "killed" vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Td POLIO ADSORBED [Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine]
produced by Sanofi Pasteur Limited, is a sterile, cloudy, white, uniform suspension of tetanus and diphtheria
toxoids adsorbed on aluminum phosphate and suspended in phosphate buffered saline solution and
combined with Inactivated Poliomyelitis Vaccine for intramuscular injection only.
Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Polysorbate 80.</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine384">
		<vaccine_name>TENIVAC</vaccine_name>
		<proper_name>Tetanus and Diphtheria Toxoids Adsorbed For Adult Use</proper_name>
		<brand_name>TENIVAC</brand_name>
		<manufacturer>Sanofi Pasteur, Ltd</manufacturer>
		<vo_id>VO_0000102</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1726)</location_licensed>
		<description refs="reference808">Is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older(FDA: Tenivac)</description>
		<adjuvant refs="">Aluminum Phosphate</adjuvant>
		<storage refs="">TENIVAC vaccine should be stored at 2° to 8°C (35° to 46°F). DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference808">Clostridium tetani is grown in modified Mueller-Miller casamino acid medium without beef heart infusion. Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration. (FDA: Tenivac)</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response482" host_id="host2">
			<immune_response refs="reference808">Among adults 65 years of age and over who received TENIVAC vaccine (N = 419), 94.5% (95% 273 confidence interval 91.9, 96.5) had a post-vaccination diphtheria antitoxoid level 275 ≥0.1 IU/mL (FDA: Tenivac).</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="reference808">The most frequent solicited injection site reaction within 0-3 days following TENIVAC was pain, reported in 78.3% of study participants 11-59 years of age and 35.3% of participants ≥60 years of age.  Contraindicatons include pain, redness, swelling, and systemic adverse effects(FDA: Tenivac)</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine5582">
		<vaccine_name>Tetanus and Diphtheria Toxoids Adsorbed</vaccine_name>
		<proper_name>Tetanus and Diphtheria Toxoids, Adsorbed</proper_name>
		<brand_name>None</brand_name>
		<manufacturer>MassBiologics</manufacturer>
		<vo_id></vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA</location_licensed>
		<description refs="reference4103">Tetanus and Diphtheria Toxoids Adsorbed (Td) manufactured by MassBiologics is a sterile vaccine for intramuscular injection. After shaking, the vaccine appears as a homogeneous milky white suspension. Each 0.5 ml dose of MassBiologics’ Td is formulated to contain the following active ingredients: 2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid. Each 0.5 ml dose also contains aluminum adjuvant (not more than 0.53 mg aluminum by assay), &lt; 100 mcg (0.02%) of residual formaldehyde, and a trace amount of thimerosal [mercury derivative, (&lt; 0.3 mcg mercury/dose)] (not as a preservative) from the manufacturing process. (FDA: Tetanus and Diptheria Toxoids Adsorbed)</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at 2°C - 8°C (36°F - 46°F), do not freeze.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine631">
		<vaccine_name>Tetanus Toxoid Adsorbed</vaccine_name>
		<proper_name>Tetanus Toxoid Adsorbed</proper_name>
		<brand_name>Tetanus Toxoid Adsorbed</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0000109</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA, Canada</location_licensed>
		<description refs="">Products: Protein.</description>
		<adjuvant refs="">Aluminum potassium sulfate</adjuvant>
		<storage refs="">Store between 2° – 8°C (35° – 46°F).</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine313">
		<vaccine_name>Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc</vaccine_name>
		<proper_name>Tetanus Toxoid Adsorbed</proper_name>
		<brand_name>None</brand_name>
		<manufacturer>Sanofi Pasteur, Inc.</manufacturer>
		<vo_id>VO_0000033</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (License #1725)</location_licensed>
		<description refs="reference749">Tetanus Toxoid Adsorbed manufactured by Aventis Pasteur Inc., for intramuscular injection, is a sterile suspension of alum-precipitated (aluminum potassium sulfate) toxoid in an isotonic sodium chloride solution (FDA: Tetanus Toxoid Adsorbed).</description>
		<adjuvant refs="">aluminum potassium sulfate (alum)</adjuvant>
		<storage refs="">Store between 2° – 8°C (35° – 46°F). DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference749">C. tetani culture is grown in a peptone-based medium containing an extract of bovine muscle tissue and detoxified with formaldehyde. The detoxified material is purified by serial ammonium sulfate fractionation and diafiltration, followed by sterile filtration. The toxoid is adsorbed to aluminum potassium sulfate (alum). The adsorbed toxoid is diluted with physiological saline solution (0.85%) (FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc).</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response475" host_id="host2">
			<immune_response refs=""></immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs="">Side effects of vaccination are: injection site reactions, fever, and nausea.</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine314">
		<vaccine_name>Tetanus Toxoid by Sanofi Pasteur Inc</vaccine_name>
		<proper_name>Tetanus Toxoid</proper_name>
		<brand_name></brand_name>
		<manufacturer>Sanofi Pasteur, SA</manufacturer>
		<vo_id>VO_0000110</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route></route>
		<location_licensed>USA (License #1724)</location_licensed>
		<description refs="reference2076">Tetanus Toxoid is interchangeable with Tetanus Toxoid Adsorbed (contains aluminum adjuvant) as a booster, and would only be preferred if aluminum was to be avoided. Although the rate of seroconversion is essentially equivalent with either form, adsorbed toxoids induce more persistent antitoxin titers.2 Tetanus Toxoid would be preferred over diphtheria-containing vaccines if there was a contraindication to the diphtheria component (FDA: Tetanus Toxoid).</description>
		<adjuvant refs=""></adjuvant>
		<storage refs="">Store at 2° to 8°C (35° to 46°F). DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs=""></route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine3057">
		<vaccine_name>Tetanus Toxoid with Calcium Phosphate</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer></manufacturer>
		<vo_id>VO_0004230</vo_id>
		<type>Toxoid vaccine</type>
		<status>Research</status>
		<vector></vector>
		<route>subcutaneous injection</route>
		<location_licensed></location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">subcutaneous injection</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response887" host_id="host3">
			<immune_response refs="reference1888">Mice immunized with CP-TT had IgG levels than mice immunized with TT adsorbed to aluminum phosphate (Gupta and Siber, 1994).</immune_response>
			<host_strain refs="">BALB/c</host_strain>
			<vaccination_protocol refs="reference1888">MIce were injected with TT preparation subcutaneously and boosted 30 days later (Gupta and Siber, 1994)</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs=""></side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine3058">
		<vaccine_name>Tetanus Toxoid with Stearyl Tyrosine</vaccine_name>
		<proper_name></proper_name>
		<brand_name></brand_name>
		<manufacturer></manufacturer>
		<vo_id>VO_0004231</vo_id>
		<type>Toxoid vaccine</type>
		<status>Research</status>
		<vector></vector>
		<route>subcutaneous injection</route>
		<location_licensed></location_licensed>
		<description refs=""></description>
		<adjuvant refs=""></adjuvant>
		<storage refs=""></storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">subcutaneous injection</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response888" host_id="host3">
			<immune_response refs="reference1888">Mice immunized with stearyl tyrosine TT had lower IgG responses than in mice immunized with TT adsorbed to aluminum phosphate (Gupta and Siber, 1994).</immune_response>
			<host_strain refs="">BALB/c</host_strain>
			<vaccination_protocol refs="reference1888">Mice were injected with TT preparation subcutaneously and boosted 30 days later (Gupta and Siber, 1994).</vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs=""></protection_efficacy>
			<side_effects refs=""></side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<vaccine vaccine_id="vaccine633">
		<vaccine_name>Tripacel</vaccine_name>
		<proper_name>Pertussis Vaccine-Acellular, Combined with Diphtheria and Tetanus Toxoids (Adsorbed)</proper_name>
		<brand_name>Tripacel</brand_name>
		<manufacturer>Sanofi Pasteur Ltd</manufacturer>
		<vo_id>VO_0010742</vo_id>
		<type>Subunit vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>Canada</location_licensed>
		<description refs="">Products: Proteins. Other components: Formaldehyde, Glutaraldehyde.</description>
		<adjuvant refs="">Aluminum phosphate</adjuvant>
		<storage refs="">Store at at 2° to 8°C.</storage>
		<virulence refs=""></virulence>
		<preparation refs=""></preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
	</vaccine>
	<vaccine vaccine_id="vaccine366">
		<vaccine_name>Tripedia</vaccine_name>
		<proper_name>Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed</proper_name>
		<brand_name>Tripedia</brand_name>
		<manufacturer>Sanofi Pasteur, Inc.</manufacturer>
		<vo_id>VO_0000112</vo_id>
		<type>Toxoid vaccine</type>
		<status>Licensed</status>
		<vector></vector>
		<route>Intramuscular injection (i.m.)</route>
		<location_licensed>USA (FDA License #1725)</location_licensed>
		<description refs="reference807">Tripedia vaccine combines diptheria and tetanus toxoids with purified pertussis antigens. It consists of 3 doses administered at intervals of 4-8 weeks(FDA: Tripedia)</description>
		<adjuvant refs="">aluminum potassium sulfate</adjuvant>
		<storage refs="">Store between 2 and 8 degrees Celsius. DO NOT FREEZE.</storage>
		<virulence refs=""></virulence>
		<preparation refs="reference807">Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract.  It is then detoxified with formaldehyde and seperately purified by serial ammonium sulfate fractionation and diafiltration.(FDA: Tripedia)</preparation>
		<route refs="">Intramuscular injection (i.m.)</route>
		<antigen refs=""></antigen>
		<host_response host_response_id="host_response480" host_id="host2">
			<immune_response refs="reference807">Overall seroconversion rates in chuldren who received ActHIB reconstituted with Tripedia vaccine were 98%, 98%, and 96% for measles, mumps, and rubella, respectively.(FDA: Tripedia)</immune_response>
			<host_strain refs=""></host_strain>
			<vaccination_protocol refs=""></vaccination_protocol>
			<persistence refs=""></persistence>
			<immune_response_type refs=""></immune_response_type>
			<immune_response_type refs=""></immune_response_type>
			<protection_efficacy refs="reference807">Complete immunization significantly reduces the risk of developing diptheria and protection is said to last around 10 years.(FDA: Tripedia)</protection_efficacy>
			<side_effects refs="reference807">Side effects of vaccination include: injection site reactions, fevver, irritability, drowsiness, and vomiting. In some cases with infant immunization, anorexia and an unusual hig-pitched cry were reported(FDA: Tripedia)</side_effects>
			<challenge_protocol refs=""></challenge_protocol>
			<description refs=""></description>
		</host_response>
	</vaccine>
	<gene gene_id="gene451">
        <gene_name>TTC</gene_name>
        <strain></strain>
        <vo_id>VO_0010909</vo_id>
        <ncbi_gene_id></ncbi_gene_id>
        <ncbi_nucleotide_id></ncbi_nucleotide_id>
        <ncbi_protein_id>157829735</ncbi_protein_id>
        <gene_locus_tag></gene_locus_tag>
        <gene_refseq></gene_refseq>
        <protein_refseq></protein_refseq>
        <pdb_id>1A8D</pdb_id>
        <xrefs>CDD:285228
CDD:285226</xrefs>
        <taxonomy_id>1513</taxonomy_id>
        <chromosome></chromosome>
        <segment></segment>
        <plasmid></plasmid>
        <gene_start></gene_start>
        <gene_end></gene_end>
        <gene_strand>?</gene_strand>
        <protein_name></protein_name>
        <protein_pi>6.63</protein_pi>
        <protein_weight>50172.35</protein_weight>
        <protein_length>506</protein_length>
        <protein_note>NCBI Domains</protein_note>
        <protein_annotation></protein_annotation>
        <dna_sequence></dna_sequence>
        <protein_sequence>>pdb|1A8D|A Chain A, Tetanus Toxin C Fragment
MKNLDCWVDNEEDIDVILKKSTILNLDINNDIISDISGFNSSVITYPDAQLVPGINGKAIHLVNNESSEV
IVHKAMDIEYNDMFNNFTVSFWLRVPKVSASHLEQYGTNEYSIISSMKKHSLSIGSGWSVSLKGNNLIWT
LKDSAGEVRQITFRDLPDKFNAYLANKWVFITITNDRLSSANLYINGVLMGSAEITGLGAIREDNNITLK
LDRCNNNNQYVSIDKFRIFCKALNPKEIEKLYTSYLSITFLRDFWGNPLRYDTEYYLIPVASSSKDVQLK
NITDYMYLTNAPSYTNGKLNIYYRRLYNGLKFIIKRYTPNNEIDSFVKSGDFIKLYVSYNNNEHIVGYPK
DGNAFNNLDRILRVGYNAPGIPLYKKMEAVKLRDLKTYSVQLKLYDDKNASLGLVGTHNGQIGNDPNRDI
LIASNWYFNHLKDKILGCDWYFVPTDEGWTND

</protein_sequence>
        <phi_function>Protective antigen</phi_function>
        <phi_annotation>The fragment C of tetanus toxin was amplified from Clostridium tetani DNA by PCR.  Immunization of mice with rTTC resulted in the production of antibodies that were able to protect mice against a challenge with tetanus toxin furthermore, rTTC in vivo appeared to be able to undergo retrograde axonal transport [Ref1073:He et al., 2000].</phi_annotation>
        <phi_function2></phi_function2>
        <phi_annotation2></phi_annotation2>
    </gene>
	<reference reference_id="reference2333">
		<reference_name>Anderson et al., 1997</reference_name>
		<reference_type>journal</reference_type>
		<authors>Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G</authors>
		<title>Immunization of mice with DNA encoding fragment C of tetanus toxin</title>
		<year>1997</year>
		<volume>15</volume>
		<issue>8</issue>
		<pages>827-829</pages>
		<journal_book_name>Vaccine</journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url></url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference711">
		<reference_name>Brook, 2008</reference_name>
		<reference_type>journal</reference_type>
		<authors>Brook I</authors>
		<title>Current concepts in the management of Clostridium tetani infection</title>
		<year>2008</year>
		<volume>6</volume>
		<issue>3</issue>
		<pages>327-336</pages>
		<journal_book_name>Expert review of anti-infective therapy</journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url></url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference809">
		<reference_name>FDA Boostrix</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA Boostrix</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference810">
		<reference_name>FDA Decavac</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA Decavac</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094067.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference785">
		<reference_name>FDA Infanrix</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA Infanrix</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference806">
		<reference_name>FDA: Adacel</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Adacel</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference787">
		<reference_name>FDA: DAPTACEL</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: DAPTACEL</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101572.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference786">
		<reference_name>FDA: dttadLB</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Diphtheria and Tetanus Toxoids Adsorbed USP</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094012.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference789">
		<reference_name>FDA: KINRIX</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: KINRIX</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference788">
		<reference_name>FDA: Pediarix</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Pediarix</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference790">
		<reference_name>FDA: Pentacel</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Pentacel Vaccine</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4109">
		<reference_name>FDA: Quadracel</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Quadracel vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM439903.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference808">
		<reference_name>FDA: Tenivac</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Tenivac</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM152826.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4103">
		<reference_name>FDA: Tetanus and Diptheria Toxoids Adsorbed</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Tetanus and Diphtheria Toxoids Adsorbed vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM164127.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference2076">
		<reference_name>FDA: Tetanus Toxoid</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Tetanus Toxoid</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm166863.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference749">
		<reference_name>FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Tetanus Toxoid Adsorbed by Sanofi Pasteur Inc</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094068.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference807">
		<reference_name>FDA: Tripedia</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>FDA: Tripedia</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101565.htm</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4107">
		<reference_name>GSK: Boostrix-Polio</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>GSK: Boostrix-Polio vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://ca.gsk.com/media/589683/boostrix-polio.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4111">
		<reference_name>GSK: Infanrix-hexa</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>GSK: Infanrix-hexa vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://ca.gsk.com/media/537989/infanrix-hexa.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4108">
		<reference_name>GSK: Infanrix-IPV</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>GSK: Infanrix-IPV vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://ca.gsk.com/media/590851/infanrix-ipv.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4110">
		<reference_name>GSK: Infanrix-IPV/Hib</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>GSK: Infanrix-IPV/Hib vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>http://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference1888">
		<reference_name>Gupta and Siber, 1994</reference_name>
		<reference_type>journal</reference_type>
		<authors>Gupta RK, Siber GR</authors>
		<title>Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid</title>
		<year>1994</year>
		<volume>22</volume>
		<issue>1</issue>
		<pages>53-63</pages>
		<journal_book_name>Biologicals : journal of the International Association of Biological Standardization</journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url></url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference1073">
		<reference_name>He et al., 2000</reference_name>
		<reference_type>journal</reference_type>
		<authors>He HJ, He ZY, Shi HJ, Zhu W, Yang GZ, Yuan QS, Wu XF</authors>
		<title>Cloning and Expression of Tetanus Toxin Fragment C in E.coli</title>
		<year>2000</year>
		<volume>32</volume>
		<issue>4</issue>
		<pages>322-326</pages>
		<journal_book_name>Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica</journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url></url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference3340">
		<reference_name>Medaglini et al., 2001</reference_name>
		<reference_type>journal</reference_type>
		<authors>Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G</authors>
		<title>Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice</title>
		<year>2001</year>
		<volume>19</volume>
		<issue>15-16</issue>
		<pages>1931-1939</pages>
		<journal_book_name>Vaccine</journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url></url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4106">
		<reference_name>Product Monograph: Adacel-Polio</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>Product Monograph: Adacel-Polio vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4112">
		<reference_name>Product Monograph: Pediacel</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>Product Monograph: Pediacel vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.vaccineshoppecanada.com/document.cfm?file=Pediacel_E.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4104">
		<reference_name>Product Monograph: Td Adsorbed</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>Product Monograph: Td Adsorbed vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.vaccineshoppecanada.com/document.cfm?file=td_adsorbed_e.pdf</url>
		<file_name></file_name>
	</reference>
	<reference reference_id="reference4105">
		<reference_name>Product Monograph: Td Polio Adsorbed</reference_name>
		<reference_type>website</reference_type>
		<authors></authors>
		<title>Product Monograph: Td Polio Adsorbed vaccine information</title>
		<year></year>
		<volume></volume>
		<issue></issue>
		<pages></pages>
		<journal_book_name></journal_book_name>
		<publisher></publisher>
		<publisher_location></publisher_location>
		<book_editors></book_editors>
		<isbn></isbn>
		<university></university>
		<university_location></university_location>
		<degree></degree>
		<url>https://www.vaccineshoppecanada.com/document.cfm?file=td_polio_adsorbed_e.pdf</url>
		<file_name></file_name>
	</reference>
</VIOLIN>


